Detailed analyses of structural alterations and CNVs of this tumor revealed a gain at the NRG3 gene, a ligand for ERBB4 and ERBB3 receptors, that was previously shown to play a role in ERBB pathway activation (Liu et al., 2016). Here, EGFR is linked to neoplasm.